Ayikpoe, Richard S.
Shi, Chengyou http://orcid.org/0000-0003-1138-3580
Battiste, Alexander J. http://orcid.org/0000-0002-4072-7007
Eslami, Sara M.
Ramesh, Sangeetha http://orcid.org/0000-0002-9229-2009
Simon, Max A. http://orcid.org/0000-0002-4183-8040
Bothwell, Ian R.
Lee, Hyunji
Rice, Andrew J. http://orcid.org/0000-0001-8794-3826
Ren, Hengqian
Tian, Qiqi
Harris, Lonnie A.
Sarksian, Raymond
Zhu, Lingyang http://orcid.org/0000-0002-6657-271X
Frerk, Autumn M.
Precord, Timothy W.
van der Donk, Wilfred A. http://orcid.org/0000-0002-5467-7071
Mitchell, Douglas A. http://orcid.org/0000-0002-9564-0953
Zhao, Huimin http://orcid.org/0000-0002-9069-6739
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AI144967)
Article History
Received: 9 April 2022
Accepted: 6 October 2022
First Online: 17 October 2022
Competing interests
: D.A.M. is a co-founder and owns stock options in Lassogen, Inc. D.A.M., W.A.vdD., and H.Z. declare that a provisional patent application based on the methods described within has been filed with the University of Illinois Office of Technology Management (US63/354,994 (2022)). The remaining authors declare no other competing interests.